Elixirgen Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Elixirgen Therapeutics is a clinical-stage orphan drug company that recently received Rare Pediatric Disease, Orphan Drug, and Regenerative Medicine Advanced Therapy (RMAT) FDA Designations for its autologous cell therapy for telomere biology disorders, and is also developing an all-in-one platform for mRNA therapeutics .
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}